DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Nowak-Göttl U, Dietrich K, Schaffranek D. et al.
In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes.
Blood 2010;
116 (26) 6101-6105
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.